Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Thirumalai Chemicals Limited (TIRUMALCHM.NS)
Mumbai, IN
Thirumalai Chemicals Limited, founded in 1972 and based in Mumbai, India, specializes in the manufacturing and sale of organic chemicals domestically. The company's product offerings include key compounds such as phthalic anhydride, maleic anhydride, malic acid, fumaric acid, and diethyl phthalate. Beyond chemical production, Thirumalai Chemicals also operates wind-powered generators for electricity generation and provides expert engineering and technical services. Its chemical products are crucial to a wide array of industries, including plastics, paints, food, cosmetics, and pharmaceuticals. Furthermore, the company has a global footprint, exporting its chemical portfolio to approximately 34 countries.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.89% | -17.08% | -16.30% | -0.07% | -22.82% | -24.24% | -34.21% | -3.59% | +32.99% | +537.43% | +4,126.95% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%-15.3% Q1'26: -18.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-231.3% Q1'26: -69.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-16.9% Q1'26: -148.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-7.1% Q1'26: -3.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-3.6% Q1'26: -1.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+9.9% Q1'26: +17.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-61.85× Q1'26: 88.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
|---|---|---|---|---|---|
| Revenue |
10.33B
est: 10.36B (-0.3%)
|
13.11B
est: 14.08B (-6.9%)
|
12.58B
est: 14.26B (-11.8%)
|
10.82B
est: 16.66B (-35.0%)
|
10.85B
est: 19.75B (-45.1%)
|
| EBITDA |
1.61B
est: 1.23B (+31.0%)
|
2.96B
est: 1.64B (+81.0%)
|
2.12B
est: 1.66B (+27.8%)
|
963.60M
est: 2.41B (-60.0%)
|
2.28B
est: 2.36B (-3.4%)
|
| EBIT |
1.25B
est: 896.32M (+39.2%)
|
2.59B
est: 1.68B (+54.6%)
|
1.76B
est: 1.21B (+45.1%)
|
522.90M
est: 2.03B (-74.2%)
|
1.78B
est: 1.72B (+3.6%)
|
| Net Income |
705.45M
est: 842.53M (-16.3%)
|
1.70B
est: 1.84B (-7.4%)
|
1.14B
est: 1.90B (-40.2%)
|
231.70M
est: 1.35B (-82.8%)
|
1.18B
est: 4.89B (-75.9%)
|
| SGA |
522.88M
est: 514.77M (+1.6%)
|
672.80M
est: 685.91M (-1.9%)
|
601.80M
est: 694.52M (-13.4%)
|
587.40M
est: 1.64B (-64.1%)
|
553.90M
est: 986.56M (-43.9%)
|
| EPS |
6.90
est: 8.22 (-16.1%)
|
16.65
est: 18.05 (-7.8%)
|
11.09
est: 18.62 (-40.4%)
|
2.26
est: 29.44 (-92.3%)
|
11.49
est: 47.48 (-75.8%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-03 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-02 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Rangaswamy Parthasarathy | Chairman & MD | 33M | male |
| Ramya Bharathram | Chief Financial Officer, MD & Whole-Time Director | 22M | female |
| Mohana Chandran Nair | Whole-Time Director | 729.3K | male |
| R. Srinivasaraghavan | President Factory Operations | — | male |
| S. Varadharajan | Vice President of Marketing | — | male |
| Sanjay Sinha | Chief Executive Officer | — | male |
| Harshit D. Kapoor | Executive Vice President | — | male |
| V. Thirumalaisamy | Executive Vice President of Project & Engineering | — | male |
| J. Radha | Executive Vice President of Finance | — | female |
| Krishnamurthy | Executive Vice President of Accounts & Systems | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TIRUMALCHM.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
